- Home
- CNC
as 09-06-2024 4:00pm EST
Centene is a managed-care organization focused on government-sponsored healthcare plans, including Medicaid, Medicare, and the individual exchanges. Centene served 24 million medical members as of June 2023, mostly in Medicaid (67% of membership), the individual exchanges (14%), and Medicare Advantage (6%) plans. The company also serves traditional Medicare users with its Medicare Part D pharmaceutical program.
| Founded: | 1984 | Country: | United States |
| Employees: | N/A | City: | ST LOUIS |
| Market Cap: | 41.3B | IPO Year: | 2001 |
| Target Price: | $85.75 | AVG Volume (30 days): | 3.1M |
| Analyst Decision: | Buy | Number of Analysts: | 12 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | 5.26 | EPS Growth: | 9.18 |
| 52 Week Low/High: | $63.45 - $81.42 | Next Earning Date: | 10-22-2024 |
| Revenue: | $144,064,000,000 | Revenue Growth: | 4.32% |
| Revenue Growth (this year): | N/A | Revenue Growth (next year): | 3.33% |
Latest Centene Corporation News
CNC Breaking Stock News: Dive into CNC Ticker-Specific Updates for Smart Investing
Zacks
2 days ago
Centene's Unit Secures New Four-Year Medicaid Contract in Iowa
Morningstar Research
2 days ago
Analyst Report: Centene Corporation
Zacks
2 days ago
Here's Why Centene (CNC) is a Strong Value Stock
Healthcare Dive
3 days ago
Mississippi awards Medicaid contracts to Centene, Molina, TrueCare
PR Newswire
3 days ago
WellCare of North Carolina Donates $100,000 to Support Camp HOPE America
Investopedia
3 days ago
Health Insurer Stocks Tumble on Medicaid Enrollment Concerns
MT Newswires
3 days ago
Nephron Research Adjusts Price Target on Centene to $86 From $88
MT Newswires
3 days ago
Centene's Iowa Total Care Gets 4-Year Medicaid Contract
Compare CNC vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "CNC Centene Corporation - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.